DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 58 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $758,000 | -92.5% | 128,926 | -71.2% | 0.06% | -85.5% |
| Q2 2016 | $10,043,000 | +719.8% | 447,958 | +96.1% | 0.42% | +904.8% |
| Q1 2016 | $1,225,000 | -58.7% | 228,468 | -8.6% | 0.04% | -55.3% |
| Q4 2015 | $2,968,000 | +20.5% | 250,000 | -16.7% | 0.09% | +70.9% |
| Q3 2015 | $2,463,000 | -41.1% | 300,000 | 0.0% | 0.06% | -33.7% |
| Q2 2015 | $4,185,000 | -41.9% | 300,000 | 0.0% | 0.08% | -43.5% |
| Q1 2015 | $7,209,000 | +46.0% | 300,000 | 0.0% | 0.15% | +42.7% |
| Q4 2014 | $4,939,000 | +29.4% | 300,000 | 0.0% | 0.10% | +18.4% |
| Q3 2014 | $3,818,000 | +322.8% | 300,000 | +650.0% | 0.09% | +335.0% |
| Q2 2014 | $903,000 | -20.1% | 40,000 | 0.0% | 0.02% | -16.7% |
| Q1 2014 | $1,130,000 | – | 40,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
| Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
| EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
| RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
| BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
| Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
| Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
| DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
| EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |